Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylphosphonic Acid Diisopropyl Ester SCHEMBL472052 | 0.87 | CTSA (0.53) | CTSAACHEALDH1A1KDM4EPOLB | |
| Methylphosphonic Acid Diisopropyl Ester SCHEMBL18492287 | 0.79 | CA2 (0.47) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL15043603 | 0.79 | — | — | |
| SCHEMBL10308497 | 0.73 | — | — | |
| SCHEMBL29385539 | 0.73 | — | — | |
| SCHEMBL3628442 | 0.71 | CTSA (0.50) | CTSAACHEALDH1A1KDM4EPOLB | |
| Methane SCHEMBL11428409 | 0.71 | — | — | |
| SCHEMBL80155 | 0.69 | CTSA (0.56) | CTSAACHEALDH1A1KDM4EPOLB | |
| Isopropyl Methylphosphonofluoridate SCHEMBL50256 | 0.69 | — | — | |
| SCHEMBL15704412 | 0.69 | CTSA (0.48) | CTSAACHEALDH1A1KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119689586-A | Fixed wing aircraft aviation magnetic measurement compensation method and system | 杭州电子科技大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119205600-A | RDH-based image low-distortion reversible contrast enhancement method | 福建理工大学 | 2024-12-27 | — | — | CN | claimed |
| CN-114027811-B | BImp pulse wave-based blood pressure calculation model and blood pressure measurement system | 北京超思电子技术有限责任公司 | 2024-05-14 | — | — | CN | claimed |
| CN-114450395-A | LOCKR-mediated CAR T cell recruitment | 华盛顿大学 | 2022-05-06 | — | — | CN | claimed |
| CN-114027811-A | Blood pressure calculation model and blood pressure measurement system based on BImp pulse wave | 北京超思电子技术有限责任公司 | 2022-02-11 | — | — | CN | claimed |
| WO-2026044343-A1 | MONITORING SYSTEM | Zaplutus IQ Pty Ltd (AU) | 2026-03-05 | — | — | WO | disclosed |
| EP-4062202-B1 | GENERATOR OF ACOUSTIC WAVES | ENI SPA (IT) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025228996-A1 | METHOD FOR PERSONALIZED THERAPY OF CELIAC DISEASE | DR. FALK PHARMA GMBH (DE) | 2025-11-06 | — | — | WO | disclosed |
| US-20250333768-A1 | RECOMBINANT YEAST CELL | DANISCO US INC (US) | 2025-10-30 | — | — | US | disclosed |
| EP-4635500-A1 | THERAPEUTIC AGENT FOR BACTERIAL INFECTION | Sumitomo Pharma Co., Ltd. (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-20250283121-A1 | RECOMBINANT YEAST CELL | DANISCO US INC (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250277240-A1 | RECOMBINANT YEAST CELL | DANISCO US INC (US) | 2025-09-04 | — | — | US | disclosed |
| CN-114027811-A | Blood pressure calculation model and blood pressure measurement system based on BImp pulse wave | 北京超思电子技术有限责任公司 | 2022-02-11 | — | — | CN | disclosed |
| US-20220038136-A1 | COMMUNICATION IN A RESONANCE MAGNETIC COUPLED SYSTEM | IDAC HOLDINGS, INC. (US) | 2022-02-03 | — | — | US | disclosed |
| US-7919481-B2 | Inositol pyrophosphates, and methods of use thereof | NORMOXYS, INC. (US) | 2011-04-05 | — | — | US | disclosed |
| US-20100256094-A1 | Inositol pyrophosphates, and methods of use thereof | NORMOXYS, INC. | 2010-10-07 | — | — | US | disclosed |
| US-7648970-B2 | Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders | NORMOXYS, INC. (US) | 2010-01-19 | — | — | US | disclosed |
| US-7618954-B2 | Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders | NORMOXYS, INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-20080200437-A1 | Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases | UNIVERSITE DE STRASBOURG (FR) | 2008-08-21 | — | — | US | disclosed |
| US-20070207986-A1 | Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders | NORMOXYS, INC. | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200437-A1 | Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases | PPIP5K2, IP6K1, IP6K3 | CTSA 3660/4885ACHE 4870/4885ALDH1A1 4593/4885 |
| US-20100256094-A1 | Inositol pyrophosphates, and methods of use thereof | PPIP5K2, ITPA, INPP5B | CTSA 4305/4885ACHE 2900/4885ALDH1A1 3004/4885 |
| US-20070207986-A1 | Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders | PPIP5K2, ITPA, INPP5B | CTSA 3920/4885ACHE 3324/4885ALDH1A1 2760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.